Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Whole Cell Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN116536279B reveals novel biocatalytic route for DHEA. Achieves high yield and purity with reduced environmental impact for pharmaceutical supply chains.
Patent CN107287256A details a novel whole-cell catalytic method for L-2-piperidinecarboxylic acid, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN109609536B reveals efficient whole-cell synthesis. Reduces cost and improves supply chain reliability for high-purity L-carnosine manufacturing.
Patent CN109609536B enables efficient L-carnosine production. Reduced costs and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN110951799B details a novel whole-cell enzymatic route for high-purity antibiotic intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Novel whole-cell method for L-menthol synthesis offers high ee and cost efficiency. Reliable supplier for flavor and fragrance intermediates with scalable green chemistry.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Novel immobilized cell method ensures high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Patent CN101285085A reveals a high-efficiency whole cell catalysis method for Adenosylmethionine, offering superior conversion rates and simplified purification for global supply chains.
Patent CN117821355A reveals efficient enzymatic synthesis for ferulic acid. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN104263776A reveals high-yield biocatalytic route for chiral pyridine ethanol offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN104059952A details immobilized cell catalysis for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global manufacturers.